JPRN-jRCT2080224520已完成3 期
A Phase 3 clinical trial of MLD-55 in pediatric patients with depression
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 12age old 至 <= 17age old（—）
- 性别
- All
入选标准
- •Patients with a primary diagnosis of major depressive disorder or persistent depressive disorder completely meeting the criteria of major depressive episode throughout the preceding 1 year according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
排除标准
- •(1)Patients with a complication or history of any of the following DSM-5-classified diseases:
- •- Bipolar and related disorders
- •- Schizophrenia spectrum and other psychotic disorders
- •(2)Patients with a history of suicidal behavior (suicide attempt, interrupted suicide attempts) based on C-SSRS within one year prior to screening.
研究者
相似试验
已完成
2 期
Phase II/III clinical trial of L-105 in pediatric patients with hepatic encephalopathyHepatic encephalopathyJPRN-jRCT2080224978ASKA Pharmaceutical Co., Ltd.20
进行中（未招募）
1 期
A phase I/II study of LDE225 in pediatric patients with recurrent or refractory medulloblastoma or other tumors potentially dependent on the Hedgehog-signaling pathway and adult patients with recurrent or refractory medulloblastomaPhase I part: pediatric patients with recurrent or refractory medulloblastoma or other tumors potentially dependent on the Hedgehog-signaling pathway (rhabdomyosarcoma, neuroblastoma, hepatoblastoma, high-grade glioma, or osteosarcoma) Phase II part: pediatric and adult patients with recurrent or refractory medulloblastomaMedDRA version: 14.1 Level: PT Classification code 10039027 Term: Rhabdomyosarcoma recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10031296 Term: Osteosarcoma recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10019823 Term: Hepatoblastoma recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10065443 Term: Malignant glioma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10066595 Term: Neuroblastoma recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1 Level: PT Classification code 10066594 Term: Medulloblastoma recurrent System Organ Class: 10029104 - NEUCTR2010-019348-37-GBovartis Pharma Services AG76
进行中（未招募）
1 期
A phase 1 study of LDE225 in pediatric patients with recurrent or refractory medulloblastoma or other tumors potentially dependent on the Hedgehog-signaling pathwayEUCTR2010-019348-37-FRovartis Pharma Services AG24
进行中（未招募）
不适用
A phase 1 study of LDE225 in pediatric patients with refractory or recurrent medulloblastoma or other tumors potentially dependent on the Hedgehog signaling pathway - NDPatients (aged = 12 months and < 18 years) with recurrent or refractory MB, rhabdomyosarcoma, neuroblastoma, hepatoblastoma, high-grade glioma, or osteosarcoma that has progressed despite treatment with standard therapies, or for which no standard treatments are available.MedDRA version: 13.1Level: PTClassification code 10008126Term: Cerebral neuroblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 13.1Level: PTClassification code 10061750Term: Cerebellar tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-019348-37-ITOVARTIS FARMA24
已完成
1 期
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsChildhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood CraniopharyngiomaChildhood EpendymoblastomaChildhood Grade I MeningiomaChildhood Grade II MeningiomaChildhood Grade III MeningiomaChildhood High-grade Cerebellar AstrocytomaChildhood High-grade Cerebral AstrocytomaChildhood Infratentorial EpendymomaChildhood Low-grade Cerebellar AstrocytomaChildhood Low-grade Cerebral AstrocytomaChildhood MedulloepitheliomaChildhood Mixed GliomaChildhood OligodendrogliomaChildhood Supratentorial EpendymomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar AstrocytomaRecurrent Childhood Cerebral AstrocytomaRecurrent Childhood EpendymomaRecurrent Childhood MedulloblastomaRecurrent Childhood PineoblastomaRecurrent Childhood Subependymal Giant Cell AstrocytomaRecurrent Childhood Supratentorial Primitive Neuroectodermal TumorRecurrent Childhood Visual Pathway and Hypothalamic GliomaNCT00100880National Cancer Institute (NCI)45